Vaccination with Murid Herpesvirus-4 Glycoprotein B Reduces Viral Replication but Doesn't Induce Neutralization
Author Information
Author(s): Janet S. Stevenson, Philip G. Stevenson
Primary Institution: University of Cambridge, UK
Hypothesis
Can immunization with recombinant glycoprotein B (gB) induce neutralizing antibodies and protect against MuHV-4 challenge?
Conclusion
Immunization with gB reduced viral lytic replication but did not lead to detectable neutralization in mice.
Supporting Evidence
- Immunization with gB reduced MuHV-4 lytic replication in mice.
- Sera from immunized mice showed no neutralization of MuHV-4.
- Both gB and gB-N boosted antibody responses in a minority of carrier mice.
Takeaway
The study found that a vaccine made from a part of a virus can help reduce how much the virus multiplies, but it doesn't stop the virus from infecting cells.
Methodology
Mice were immunized with recombinant gB and then challenged with MuHV-4 to assess viral replication and neutralization.
Potential Biases
Potential bias in the selection of mouse strains and the limited sample size may affect the generalizability of the results.
Limitations
The study did not assess long-term immunity or the effectiveness of the vaccine in a broader population of mice.
Participant Demographics
C57BL/6 and BALB/c mice were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website